Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-30 @ 6:42 AM
Study NCT ID:
NCT06952803
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2025-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2033-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2036-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-30
First Submit QC Date:
None
Study First Post Date:
2025-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-15
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED